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INTRODUCTION 
 
Over the last 200 years average life expectancy in 
developed countries has more than doubled and is now 
above 80 years [1]. In numerous studies this linear 
increase is suggested to rise to an average life span of 
100 years or more [2–4]. This dramatic increase in life 
expectancy was largely driven by changes in lifestyle, 
sanitation and a continuous improvement of health care 
[5]. As a result, the major causes of death have shifted 
from infectious disease to chronic age-related 
conditions [6, 7]. Today, cardiovascular disease (CVD), 
cancer and respiratory disease are the most common 
causes of death worldwide [8, 9]. Other lifestyle and 
age-related conditions such as musculoskeletal disease, 
diabetes and dementia are also increasing rapidly and 
thus impact the number of disability-adjusted life years 
(DALYs), calculated in a population as the sum of the 
Years of Life Lost (YLL) due to premature mortality 
and the Years Lost due to Disability (YLD) [10, 11]. 
Therefore, strategies to promote healthy aging have 
gained great interest in developed societies. 
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Aging is a complex process that is not well understood but involves finite changes at the genetic and epigenetic 
level. Physical activity is a well-documented modulator of the physiological process of aging. It has been 
suggested that the beneficial health effects of regular exercise are at least partly mediated through its effects 
on telomeres and associated regulatory pathways. Telomeres, the region of repetitive nucleotide sequences 
functioning as a “cap” at the chromosomal ends, play an important role to protect genomic DNA from 
degradation. Telomeres of dividing cells progressively shorten with age. Leucocyte telomere length (TL) has 
been associated with age-related diseases. Epidemiologic evidence indicates a strong relationship between 
physical activity and TL. In addition, TL has also been shown to predict all-cause and cardiovascular mortality. 
Experimental studies support a functional link between aerobic exercise and telomere preservation through 
activation of telomerase, an enzyme that adds nucleotides to the telomeric ends. However, unresolved 
questions regarding exercise modalities, pathomechanistic aspects and analytical issues limit the 
interpretability of available data. This review provides an overview about the current knowledge in the area of 
telomere biology, aging and physical activity. Finally, the capabilities and limitations of available analytical 
methods are addressed. 
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The process of aging remains incompletely understood. 
A better understanding of the complex and interrelated 
biological mechanisms of aging would help to develop 
interventions that delay the aging process. 
Environmental and lifestyle factors, such as physical 
activity, nutrition, stress and smoking, are major 
determinants of the aging process [12]. In particular, 
regular exercise is a safe and cost-effective way to 
reduce morbidity and premature mortality [13]. 
However, the molecular mechanisms that mediate the 
beneficial effects of exercise are incompletely 
understood and remain an area of active research. In 
numerous observational and intervention studies the 
preservation of telomeres, the protective end-caps of all 
chromosomes, has been proposed as an appealing 
putative mechanism that contributes partially to the 
beneficial health effects of physical activity [14]. This 
review aims to provide an overview on the current 
knowledge in the area of telomere biology, aging and 
physical activity. In addition, the capabilities and 
limitations of available analytical methods will be 
addressed. 
 
Structure and function of telomeres 
 
The genetic information of eukaryotes is encoded in the 
deoxyribonucleic acid (DNA), which is packed in the 
chromosomes. With every division of mitotic cells a 
small fragment of DNA at the ends of every 
chromosome remains unreplicated due to a 
physiological phenomenon named the end-replication 
problem [15]. In order to prevent the loss of coding 
genetic information thousands of identical, non-coding 
oligonucleotides are attached to the ends of all 
chromosomes. These terminal non-coding DNA-regions 
are called telomeres. Human telomeres contain 
approximately 2,500 tandem copies of a simple 
hexanucleotide with the sequence 5'-TTAGGGn-3' [16]. 
For most of its length, telomeric DNA is double 
stranded. However, the last portion of 30–100 base pairs 
(bp) at the 3’-end of the G-rich strand is single-stranded. 
This G-rich overhang at the 3’-end is essential for 
telomere maintenance and capping [17, 18]. Telomeres 
give rise to a complex three-dimensional structure 
limiting the access of telomerase and DNA damage 
repair (DDR) enzymes to the free ends of each DNA-
strand. This three-dimensional structure is achieved 
through the binding of a highly abundant protein 
complex, named shelterin, to the telomeric 
hexanucleotide sequence 5’-TTAGGGn-3‘. The 
shelterin complex is composed of the following six-
subunits (see Table 1): telomeric repeat binding factor 1 
(TRF1), telomeric repeat binding factor 2 (TRF2), 
TRF1-interacting nuclear protein 2 (TIN2), telomeric 
overhang binding protein 1 (POT1), TIN2 and POT1 
interacting protein 1 (TPP1), and repressor-activator 
protein 1 (RAP1). TRF1 and TRF2 interact with the 
double-stranded telomeric DNA, whereas POT1 
associates with single-stranded telomeric DNA [19]. 
Through interactions with the shelterin proteins the 
terminal telomere section flips backwards resulting in 
the formation of a looped structure (t-loop). 
Furthermore, the shelterin proteins aid in displacing a 
short section of double-stranded telomeric DNA so that 
the single stranded G-rich overhang at the 3´end can be 
interposed. This structure is referred to as “D-loop” and 
protects the free end of the DNA strand from 
recognition as a strand break, which would induce 
inappropriate repair processes. 
 
The interaction between the shelterin protein subunits is 
complex and has been investigated using mouse 
conditional knock-out cells for TRF1, TRF2, POT1, 
TPP1. It has been shown in several studies that 
shelterins prevent DNA damage response (DDR) 
activity at telomeres, chromosomal rearrangements and 
cell cycle arrest, thus demonstrating a role in 
maintaining telomere function and preserving genomic 
stability [17, 18, 29]. Through the binding of TRF1 and 
TRF2 to double-stranded telomeric TTAGGGn repeats 
RAP1, TIN2, TPP1 and POT1 can be recruited. TIN2 
can bridge TRF1 and TRF2/RAP1 complexes by 
binding to both proteins simultaneously. Furthermore, 
TIN2 associates with the TPP1/POT1 heterodimer, 
which is typically bound to single-stranded TTAGGG 
repeats [19, 24]. These intimate interactions result in the 
formation of a “capped” loop [20, 30, 31]. 
 
Telomere length (TL) varies greatly between species 
[32]. At birth, every human individual has a specific TL 
that ranges between 5 to 15 kb [33]. Throughout life 
telomeres shorten continuously with a rate between 20-
50 bp due to the end-replication phenomenon, oxidative 
stress and other modulating factors [15, 33]. However, 
telomere shortening rates and consequently also average 
TL vary amongst different tissue types, which is at least 
partly explained by tissue-specific proliferation rates 
[34, 35]. In dividing cells, the end replication problem is 
an important driver of telomere shortening that can be 
modified by other factors, such as oxidative stress or 
inflammation [33]. In postmitotic cells instead, 
oxidative stress can directly damage telomeric DNA 
and drive cells into senescence [36, 37]. The TL of 
peripheral blood leucocytes (LTL) has gained 
substantial interest as a potential marker of biological 
age [17]. Mean LTL in adults is approximately 11 kb 
and declines with an annual rate of 30-35 bp. Telomere 
attrition is most pronounced during the first two years 
of life, which are characterized by rapid somatic growth 
[34, 35, 38, 39]. The shortening of telomeres is not a 
unidirectional process since the reverse-transcriptase 
telomerase is capable of adding new hexanucleotides to 
 
www.aging-us.com 13805 AGING 
Table 1. Shelterin complex, subunits and functions. 
Shelterin subunits Function References 
Telomeric repeat binding factor 1  
(TRF1)- binds to the canonical TTAGGG 
double-stranded telomeric repeats 
Determines the structure of telomeric ends, it is 
implicated in the generation of t-loops, and it 
controls the synthesis of telomeric DNA by 
telomerase 
de Lange [20] 
Telomeric repeat binding factor 2  
(TRF2)- TRF1 paralog 
Implicated in telomere protection and telomere 
length homeostasis 
Takai et al. [21]; Artandi et 
al. [22]; Palm et al. [23] 
TRF1-interacting nuclear protein 2  
(TIN2)- can bridge TRF1 and TRF2/RAP1 
complex and can also recruit the TPP1/POT1 
heterodimer 
Responsible for the recruitment of other 
shelterins, therefore implicated in telomere 
protection 
Lei et al. [24] 
Telomeric overhang binding protein 1  
(POT1)- associates with the single-stranded 
TTAGGG repeats 
The telomere length maintenance is exerted 
through the interaction between POT1 and the 
reverse-transcriptase ribonucleoprotein 
telomerase 
Baumann et al. [25]; Loayza 
et al. [26] 
TIN2 and POT1 interacting protein 1  
(TPP1) 
Required for the recruitment of telomerase to 
the DNA 
van Steensel et al. [27] 
Repressor-activator protein 1  
(RAP1)- 1:1 complex with TRF2 
In addition to its telomeric function, also 
implicated in the upregulation of energy 
metabolism as a modulator of the NF-κB 
signalling pathway 
de Lange [20]; Teo et al. 
[28] 
 
telomeric ends [40, 41]. However, most somatic cells do 
not express telomerase. Detectable levels of telomerase 
activity can typically be found in germ line and 
embryonic stem cells, immune cells and in cancer cells 
[42, 43]. Human telomerase is made up of two main 
components: telomerase reverse transcriptase (TERT) 
and telomerase RNA component (TERC) endowed with 
a complementary sequence of telomeric DNA (3’-
AUCCC-5’), which serves as a template for telomere 
elongation [44]. It is important to note that telomerase 
expression does not necessarily parallel enzyme activity 
[44]. In the brain for example, TERT is expressed 
without detectable telomerase activity (TA) [45]. In 
contrast, PI3K/Akt and other factors can modulate TA 
independently from TERT expression [46]. In humans, 
the telomerase enzyme complex is completed by several 
associated proteins, including dyskeratosis congenita 1 
(DKC1) and NOP10 ribonucleoprotein (NOP10),  
which are essential for the maintenance of telomere 
integrity [47, 48]. 
 
In order to add new TTAGGG hexanucleotides the 
enzyme needs access to the telomere ends, which are 
hidden in the complex three-dimensional telomere 
structure [31]. Therefore, telomeres can change their 
conformational status between an ‘open’ state, where 
the enzyme has substrate access, and a “closed” state 
that prevents telomerase action [49]. Shelterin proteins 
play a key role in regulating the conformational state of 
telomeres and thus modulate TA [27, 50]. The low 
number of TRF1 and POT1 binding sites on short 
telomeres drives the formation of an open state. 
Whereas longer telomeres, with more TRF1 and POT1 
binding sites, typically assume a closed configuration 
[26]. In this way, telomerase can be efficiently directed 
to the shortest telomeres within a cell, and sufficiently 
long telomeres will not undergo any inappropriate 
lengthening [51, 52]. 
 
The importance of TL and TA in the aging process has 
been described by Rudolph et al. demonstrating that age-
dependent telomere shortening, and genetic instability 
are associated with shortened life span and a reduced 
regenerative potential [53]. Several genetic disorders 
with mutations in loci encoding for shelterin and 
telomerase subunits have also been described, all of 
which have been characterized by an accelerated rate of 
telomere attrition [54–56]. Higher rates of leucocytes 
telomere attrition are also associated with elevated risk 
of coronary artery disease, myocardial infarction, heart 
failure and stroke [57]. Additionally, changes in LTL, 
shelterin expression and function have been linked to 
structural changes in the thoracic aorta vessel wall and 
the myocardium [58, 59]. Furthermore, shorter LTL is 
related to the increased severity of CVD [60–62]. Many 
factors contribute to the shortening of telomeres 
including the genetic background [56, 63–65], gender 
[66], socioeconomic status and consequent stress 
perceived [58, 67, 68], dietary behaviour (i.e. antioxidant 
intake, alcohol consumption etc.) [69–73], body mass 
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index (BMI) [66, 74], smoking [66, 75] and physical 
inactivity [76]. 
 
Telomere length and telomerase activity – key 
mediators of mortality and morbidity 
 
Based on the principles of telomere physiology 
explained earlier, it has been speculated that longer 
telomeres and high TA are beneficial for healthy aging 
[77]. In epidemiologic studies, adult men and women 
with shorter telomeres are characterized by higher 
mortality rate, which is nearly twice as high as in those 
with longer telomeres [78, 79]. It has been demonstrated 
that those with the shortest telomeres were characterized 
by a higher hazard ratio for all-cause mortality compared 
to those with the longest telomeres (1.66, 95%CI 1.09–
2.53, p=0.018) [80]. In addition, a reduced LTL seems to 
indicate an existing or an elevated risk for future age-
related disease such as CVD, type 2 diabetes mellitus 
(T2DM), neurodegenerative diseases, osteoporosis and 
premature aging syndromes [56, 57, 81–83]. Recent 
clinical association studies unveiled a correlation 
between leucocytes telomere attrition and clonal 
hematopoiesis of indeterminate potential (CHIP) [84]. 
During aging hematopoietic stem cells (hSC) start to 
accumulate somatic mutations. It can happen that 
through the accumulation of DNA damage one cell gains 
a competitive expansion advantage that gives rise to 
expanded clones of leucocytes with the same mutations. 
The prevalence of CHIP is very low in those aged <40 
years, but can be found in >10% of those aged 70 years 
and in approximately 20% of octogenarians [84–87]. 
Individuals who harbour these mutated clones are at 
higher risk of hematological malignancies, but also 
several adverse cardiovascular outcomes [88]. In a 
whole-genome sequencing study, the strongest 
association of CHIP was found to be an 8 bp deletion in 
intron 3 of the TERT gene. Accordingly, TLs were 
observed to be significantly shortened in CHIP carriers 
[89]. Experimental studies demonstrate a delay in aging 
and an extended median life span in mice who have been 
genetically modified with constitutively expressed 
TERT compared to the respective controls [42, 43]. 
Moreover, telomerase reactivation reverses tissue 
degeneration in telomerase deficient mice [90]. On the 
contrary, constant expression of telomerase has been 
associated with carcinogenesis and is shown to have 
detrimental effects [91, 92]. Indeed, 85 to 90% of all 
human cancers have detectable TA [91]. A pivotal role 
of telomerase in cancer biology is further highlighted by 
the fact that inhibition of TA, in telomerase-positive 
human cancer cells, induces cell death and reduces 
tumour growth [93–96]. While constant unregulated TA, 
activation of oncogenes and/or silencing of tumor 
suppressor genes appears to drive tumour incidence and 
growth [97], a physiologically regulated telomerase 
activation appears to have beneficial health effects in 
mice and humans [59, 98, 99]. Therefore, substantial 
effort has been invested in the search for lifestyle factors 
that can modulate TA including nutrition or 
psychological stress. Based on existing data, also 
physical activity appears to be an effective way to 
induce telomerase and to preserve TL [59, 98, 100]. In 
the following sections, we review existing data on the 
effects of exercise on aging and in particular on telomere 
physiology. 
 
Exercise, health and telomeres 
 
Regular exercise is a well-established approach to 
reduce the risk of morbidity and premature mortality 
[13, 101]. Prospective cohort studies demonstrate that 
men and women who regularly exercise, have a 30% 
lower all-cause mortality risk than sedentary individuals 
[13, 101]. In the older persons the beneficial effects of 
regular physical activity (above 200 minutes a day) are 
even more pronounced reaching up to >40% mortality 
risk reduction [101–103]. Some studies have calculated 
that the gain of life years ranges between 2 to 4 years 
depending on the individual level of activity [104–108]. 
Despite strong evidence that supports beneficial health 
effects through regular exercise, comparability between 
individual studies is limited because of differences in the 
composition of study cohorts, exercise protocols and the 
duration of follow-up [104–108]. However, the pooled 
analysis of six major cohort studies including 632,091 
participants with diverse ethnicity and an average age of 
61 years showed that the effect of regular exercise on 
mortality is dose-dependent and already mild physical 
activity is associated with a significant reduction of 
mortality risk and a 1.8-year gain in life expectancy [13]. 
Metabolic equivalents (MET) are used to compare 
energy consumption between different activities dividing 
the actual energy expenditure of a given activity by the 
energy expenditure at rest [109]. Of note, even 
intermittent exercise sessions with a limited duration 
offer considerable health benefits, also in obese 
individuals and those with major risk factors [110]. The 
health effects of exercise are not only determined by the 
frequency and duration of training sessions, but also by 
the intensity. Vigorous exercise is more effective  
than mild or moderate exercise in improving 
cardiorespiratory fitness [111–113]. When adjusted to 
their specific needs and abilities, even in older 
individuals, regular physical activity attenuates the age-
dependent decline in cardiorespiratory fitness [114], 
improves mobility and physical functioning [115], and 
reduces the risk of falls [116]. 
 
Besides a substantial reduction of mortality, regular 
exercise also reduces the incidence and progression of 
coronary heart disease, hypertension, stroke, diabetes, 
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metabolic syndrome, colon cancer, breast cancer, and 
depression [101]. When compared to inactive 
individuals, physically active adults exhibit better 
cardiorespiratory fitness and muscular strength, a 
healthier body mass and composition, and a favorable 
metabolic profile [101]. Furthermore, they report better 
quality of sleep and health-related quality of life  
[101]. In a 1-year randomized controlled study regular 
aerobic exercise (moderate-intensity aerobic exercise 3 
days/week at 50–60% of the maximum heart rate reserve 
for week 1 to 7 and at 60–75% for the remainder of the 
program of 1 year) was shown to attenuate age-related 
brain atrophy and improve cognitive function in older 
individuals [117]. The authors reported that in 120 older 
persons aged 55–80 years, regular exercise improved 
memory function and age-related brain atrophy was 
reversed by approximately 1-2 years [117]. A key 
mechanism that mediates the neuronal effects of aerobic 
exercise is the secretion of neurotrophins, and in 
particular brain-derived neurotrophic factor (BDNF) 
[118–120]. 
 
Despite the existence of robust evidence for multiple 
health benefits of regular exercise, the underlying 
mechanisms are insufficiently understood. General key 
mechanisms that drive the process of aging include  
the accumulation of genetic damage, epigenetic 
modifications and shortening of telomeres [121]. It has 
been speculated that exercise can help preserve TL 
through the induction of telomerase [99, 122]. In the 
following section the scientific evidence addressing this 
concept is reviewed. 
 
Exercise and telomere biology: animal studies 
 
Although human studies suggest that regular exercise 
preserves telomeres, they are unable to unveil the 
underlying mechanisms. Animal models can help to 
close this gap as they allow to investigate on the 
mechanistic pathways. At present, only very few animal 
studies have been performed [59, 98, 123, 124]. It 
appears that telomeres of murine blood leucocytes and 
other cell types (e.g. myocardium, liver, aorta) also 
become shorter with advancing age [59, 98, 123]. 
However, this process is rather slow and may take 
between 12 to 18 months. For example, TL of blood 
leucocytes and cardiomyocytes was comparable in 3-
week-old and 6-month-old C57/Bl6 mice, but was 
significantly reduced after 18 months [59, 98]. 
Interestingly, the myocardium of these exercising mice 
also showed increased telomerase and shelterin 
expression and a reduction of apoptosis and cell-cycle 
arrest [59, 98, 100]. Regular running exercise has been 
shown to attenuate the age-related erosion of TL in 
hepatocytes and cardiomyocytes of CAST/Ei J mice, a 
wild-derived inbred strain of mice, over a period of 1 
year [123]. Moreover, in skeletal muscles and 
cardiomyocytes the age-related shortening of telomeres 
is accompanied by a decreased gene expression of the 
shelterin components TRF1 and TRF2 [123]. Chronic 
exercise can counteract the reduced expression of 
shelterins and thus aid to stabilize telomeres [123]. 
TRF1 and TRF2 protein content showed similar trends 
that failed to reach significance. In line with these 
results, Werner et al. reported a persistent up-regulation 
of cardiac telomere-stabilizing proteins TRF2 and TERT 
after 6 months of daily running exercise [98]. In parallel, 
the senescence-related proteins Chk2, p53, and p16 were 
down-regulated. Together, these effects lead to a 
substantial reduction of apoptotic cardiomyocytes in the 
heart of exercising mice. Regular running exercise also 
ameliorated the cardiotoxic effects of doxorubicin [98]. 
Overall, experimental studies suggest that the beneficial 
cardiac effects of regular exercise are primarily mediated 
by TERT, eNOS, and IGF-1. 
 
Exercise-mediated telomere preservation and other 
beneficial health outcomes are most likely the result of 
a cumulative effect over an extended period of time. 
However, even a single bout of exercise has been shown 
to increase the protein levels of TRF1 and TRF2 as well 
as Pot1a, but not Pot1b gene expression [124]. These 
changes are accompanied by a greater expression of 
DNA-repair and -response genes (Chk2 and Ku80) and 
greater protein content of phosphorylated p38 MAPK 
[124]. It has been speculated that the rapid increase in 
shelterin gene expression represents a direct adaptive 
reaction to the exercise stimulus, which depends on the 
duration, intensity and type of exercise [124]. In 
contrast, the fast increase in protein content is probably 
the result of improved proteostasis rather than increased 
mRNA translation. The rapid increase of shelterin 
expression in response to a single exercise session does 
not necessarily lead to a prompt increase in TA [124]. 
However, after three weeks of regular training, a 
persistent upregulation of myocardial TERT expression 
has been shown by Werner et al. [59, 98]. This 
activation of TERT appears to be essential for the 
cardioprotective effects of physical activity. 
 
Although existing evidence is rather limited, available 
data suggest that exercise induces an immediate short-
lived regulatory response in shelterin mRNA 
expression, but only a continuous stimulation over an 
extended period of time results in a preservation of 
telomeres and delays cellular aging. Furthermore, 
regular exercise is directly involved in the establishment 
of an anti-apoptotic and anti-senescent cellular 
environment through up-regulation of genes implicated 
in the DNA damage response and repair, including 
Ku70/Ku80 and down-regulation of p16, p53 and Chk2 
[98, 123]. 
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Interestingly, the myocardium of exercising mice 
showed increased telomerase and shelterin expression 
and a reduction in apoptosis and cell-cycle arrest  
[59, 98, 100]. 
 
Exercise and telomere biology: human studies 
 
The first study to explore the relationship between 
exercise and TL in humans was conducted by Cherkas 
et al. In a cross-sectional survey of 2401 white men and 
women they showed that LTL was positively associated 
with higher physical activity levels [125]. Similar 
results were reported by Du et al. analyzing 7,813 adult 
women from the Nurses’ Health Study, where even 
moderate amounts of activity were associated with 
longer telomeres [126]. In 5823 adult men and women 
of the National Health and Nutrition Examination 
Survey (NHANES 1999-2002) Tucker et al. showed 
that average LTL decreases by 15.6 bp per year of 
chronological age [127]. Individuals with higher levels 
of physical activity had substantially longer telomeres 
in peripheral blood leucocytes, corresponding to a gain 
of biological age of approximately 9 years [127]. All 
these epidemiologic studies are limited by their cross-
sectional nature and the fact that physical activity is 
self-reported. However, several smaller studies support 
the concept of telomere preservation by regular exercise 
[128–130]. In a comparison of telomere biology in 
young and middle-aged endurance athletes with 
sedentary controls, Werner et al. demonstrated that 
regular endurance training is associated with a reduction 
in leucocyte telomere erosion [59]. In their study, LTL 
of middle-aged athletes was preserved at the level of 
young controls. In contrast, LTL of middle-aged 
controls was approximately 30-40% lower than in 
young controls and thus, demonstrating an age-related 
attenuation. The preservation of TL was confirmed by 
two independent methods, qPCR and flow-FISH. 
Furthermore, when compared with untrained 
individuals, athletes showed increased TA and 
expression of telomere-stabilizing shelterin proteins, 
such as TRF2. The effects on telomere biology were 
accompanied by a pronounced inhibition of the DNA 
damage checkpoint kinase (Chk2) and the regulators of 
cell-cycle progression and survival, termed p16 and p53 
[59]. In line with these results, Denham et al. analysed 
LTL and the expression of telomere-regulating genes in 
61 Australian endurance athletes and 61 healthy 
controls [51]. LTL in athletes was 7.1% (208-416 
nucleotides (nt)) higher than in sedentary controls. In 
addition, athletes showed a higher expression of TERT 
and TPP1 mRNA expression. Interestingly, resting 
heart rate emerged as an independent predictor of LTL, 
TERT and TPP1 mRNA expression in this study. 
Denham et al. also showed that training volume 
determines the effect of exercise on telomere biology 
with the greatest effects seen in the most active athletes. 
A much smaller study from Østhus et al. showed greater 
LTL in older endurance athletes than in individuals of 
the same age with a medium level of activity [131]. 
However, young individuals with high and low activity 
levels showed no difference in LTL. On the molecular 
level telomere-associated genes, including TERT, 
TERF2IP (which encodes RAP1), Sirtuin-6 (SIRT6) and 
TATA-box binding protein (TBP) and miRNAs that 
target these genes are upregulated after a single running 
session of 30 minutes at 80% of peak oxygen uptake 
(VO2Peak). The analysis of white blood cells from 22 
healthy male volunteers, immediately after and 60 min 
after exercise, showed that 56 miRNAs were 
differentially regulated post-exercise (FDR <0.05) and 
that 4 of these (miR-186, miR-181, miR-15a and miR-
96) potentially target telomere-associated mRNA 
species [132]. 
 
Although cross-sectional observation studies suggest 
that regular exercise preserves TL through an activation 
of telomerase, experimental and prospective studies are 
necessary to proof causality. A recent study in 124 
healthy previously inactive individuals explored the 
effects of regular endurance training, intensive interval 
training and resistance training over a period of 6 
months [99]. Participants trained 3 times per week for 
45 min. Compared to non-exercising controls, TA in 
blood mononuclear cells was up-regulated 2 to 3-fold in 
the endurance- and interval-training groups, but not in 
the resistance-training group. The activation of 
telomerase was accompanied by longer telomeres in 
lymphocytes, granulocytes, and leucocytes. In addition 
to this training study, Werner et al. also explored the 
effects of a single bout of exhaustive exercise using a 
stepwise ramp protocol on a treadmill. When compared 
to baseline, CD14+ and CD34+ leucocytes collected 
after exercise, exhibited increased TA, which was still 
measurable 24h-post exercise. IGF-1, a potential 
mediator of the exercise-induced activation of 
telomerase [59], showed a biphasic response. However, 
after the 6-month training program, IGF-1 was 
comparable to baseline levels. Furthermore, blood 
collection was performed from 48 hours to 7 days after 
the last exercise session. This suggests that whilst the 
exercise-induced effects on telomere biology are of 
short duration, any health benefit is the result of a 
cumulative effect achieved by regular training. The 
beneficial effects of long-term exercise on TL and TA 
have also been shown by Melk A et al. in 59 healthy 
middle-aged men with former sedentary lifestyles [133]. 
Besides the secretion of IGF-1, another putative 
hypothesis to explain the exercise-induced activation of 
telomerase with subsequent telomere elongation is the 
release of nitric oxide (NO) as a result of increased 
vascular shear stress [99]. Endothelial NO synthase and 
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TA appear to be linked in a signalling pathway that 
mediates vascular protection [59]. 
 
Despite robust evidence from cross-sectional and 
prospective intervention studies, not all previously 
published analyses support a relationship between 
exercise and telomere biology [134–139]. For example, 
a comparison of 17 marathon runners and 19 healthy 
sedentary controls reported no difference in LTL [136]. 
Similar findings were reported by Song et al. in 84 
healthy volunteers [135]. Finally, in a cross-sectional 
and longitudinal analyses of 582 older adults, Soares-
Miranda et al. found no consistent relationship between 
physical activity and LTL [137]. Only some general 
functional measures, such as walking distance and “chair 
test performance”, were cross-sectionally related to LTL. 
In addition, changes in leisure-time activity and in “chair 
test performance” altered the change in LTL over time. 
Results from the “Berlin Aging Study” suggest that, in 
adult men aged over 61 years, long periods of physical 
activity are necessary for the prevention of telomere 
shortening (at least 10 years), with intensive sports 
activities having the greatest effect [140]. This concept is 
confirmed by a study from Lane et al. where former elite 
athletes were found to have comparable LTL to age-
matched, sedentary individuals [141]. 
 
Some researchers suggest that the relationship between 
LTL and exercise is U-shaped [51, 142, 143]. For 
example, Savela et al. analysed physical activity levels, 
LTL and the proportion of short telomeres in 204 
randomly selected survivors of the “Helsinki 
Businessman Study”. Moderate physical activity was 
associated with the longest mean LTL. A cross-
sectional comparison of endurance athletes and healthy 
controls provides additional support that moderate 
amounts of exercise training protects against biological 
aging, while higher amounts may not elicit additional 
benefits [51]. 
 
In summary, the evidence implies that the protective 
effects of exercise require a rather long-time span and 
continuity in order to become evident. 
 
Differential effects of exercise modalities on telomere 
biology 
 
As reported above, it is not clear whether exercise can 
preserve or increase TL. The controversial results may 
be explained, in part, by the fact that “exercise” is a 
general term that includes many different types of 
physical activities, such as running, swimming, dancing, 
weightlifting, ball sports and others. Therefore, the 
question arises whether different exercise modalities 
exert differential effects on telomeres? Most existing 
studies have investigated the effects of endurance 
exercise [59, 128, 144], in particular running and 
cycling, or mixed exercise regimens [126, 129]. 
However, in most epidemiologic studies, physical 
activity was self-reported [125, 145, 146]. To date, only 
one study directly compared the effects of different 
exercise modalities on telomere biology [99]. This 
randomized controlled trial showed that only endurance 
and high-intensive interval training, but not resistance 
training, increased TA and LTL in middle-aged healthy 
individuals. All intervention groups performed 3 
exercise sessions per week with a duration of 45 min for 
6 months. In an analysis of the NHANES (1999-2001), 
different types of self-reported leisure time activities 
were assessed, and only moderate/vigorous physical 
activity was significantly associated with LTL [147]. A 
lack of resistance training to preserve TL has also been 
observed in a small cross-sectional study that compared 
power lifters with healthy, active individuals with no 
history of strength training [148]. In summary, there is 
insufficient data to judge if different training modalities 
exert differential effects on telomeres, telomerase and 
shelterin expression. However, existing studies suggest 
that aerobic endurance exercise, but not resistance 




Besides the preservation of telomeres, several other 
mechanisms have been proposed to contribute to the 
anti-aging effects of physical activity (Figure 1). Regular 
endurance exercise over 5 months improved 
mitochondrial biogenesis and morphology in skeletal 
muscles and other organs including lungs and heart in 
mtDNA mutator mice (animals with accelerated rates of 
mitochondrial DNA mutation). As a result, exercise 
delayed the age-related degeneration process of multiple 
organs, increased mobility, and attenuated telomere 
shortening [149, 150]. As noted, exercise contributes to 
an increased shelterin expression via upregulation of p38 
MAPK and a subsequent regulation of several 
transcription factors [123], including the upstream 
transcription factors of the PGC-1α gene. PGC-1α is a 
pleiotropic protein involved in cellular energy 
metabolism [151, 152] that has also been linked to aging 
[153]. During endurance exercise and caloric restriction, 
PGC-1α is activated by adenosine monophosphate-
activated protein kinase (AMPK), accumulates in the 
nucleus through sirtuin 1-dependent deacetylation and 
acts as a co-activator for other transcription factors [153, 
154] including nuclear respiratory factor 1 (NRF-1),  
a regulator of mitochondrial biogenesis [155, 156].  
Age-dependent telomere shortening contributes to 
mitochondrial and genomic DNA damage via activation 
of p53 and down-regulation of PGC-1α/β [157]. 
Recently, de Carvalho Cunha et al. have demonstrated 
that exercise regulates p53 and Chk2 in an intensity-
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dependent fashion, with high intensity endurance 
exercise being more effective in downregulating p53 
than low intensity exercise [158]. Moreover, high 
intensity training appears to be more effective in 
enhancing antioxidant defense, AMPK and PGC-1α 
expression [159]. 
 
Today, only very few animal studies have explored the 
mechanisms behind the exercise-mediated preservation 
of telomeres [59, 98, 123, 124]. Although these studies 
seem to confirm the results obtained in human studies, 
many mechanistic aspects remain to be clarified. 
Therefore, future research is needed to improve our 
understanding on the effects of exercise on telomere 
biology and genomic aging. 
Analytical aspects 
 
Despite robust evidence linking leucocyte telomere 
shortening with aging and age-related diseases, the 
measurement of LTL is not yet used clinically. Several 
unresolved pre-analytical, analytical and post-analytical 
aspects have hampered the transition of this promising 
marker from research laboratories into routine 
diagnostics. From a pre-analytical point of view the 
pronounced inter-individual variability of LTL [78, 160] 
and leucocyte telomere shortening [161] complicate a 
meaningful interpretation of individual results. Aviv et 
al. have shown that amongst young adults LTL changes 
between -240 and +12 bp per year. As previously 




Figure 1. The beneficial effects of regular physical activity. Regular physical activity exerts its beneficial effects through activation of 
telomerase, preservation of telomere length and improved mitochondrial biogenesis and function. On the cellular level these effects lead to 
the reduction of apoptosis, cellular senescence and oxidative stress, lowering the subsequent multi-system chronic inflammation. In 
summary, regular physical activity is a means to preserve genomic integrity and tissue function and reduce the onset of age-related chronic 
diseases. 
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linear process instead it is most pronounced during the 
period of rapid somatic growth in the first two years of 
life [34, 35, 38, 39]. In addition, young individuals with 
either longer or shorter than the average TL tend to 
maintain that classification throughout the rest of  
their life [162, 163]. Together, these unresolved pre-
analytical issues have prevented a consensus amongst 
researchers and clinicians as to when measurement of 
TL is meaningful and might provide a benefit for the 
individual. 
 
Another major concern is the appropriate sample matrix. 
Variable proliferation rates lead to vastly different TLs 
amongst several tissue types [35]. In different organs, 
from the same individual, TL can differ by factor 6 and 
more [35]. It also appears that TL within the same organ 
varies substantially, and consequently results depend on 
the site of sample collection. Only few studies have 
investigated the distribution of TL in different organs 
from the same donor. Perhaps normalizing LTL for TL 
of a post-mitotic tissue like fat or skeletal muscles might 
provide a better understanding of leucocyte telomere 
dynamics during aging [164]. Dlouha et al. measured 
telomere length in twelve human tissues (peripheral 
blood leukocytes, liver, kidney, heart, intercostal skeletal 
muscle, subcutaneous and abdominal fat) from dead 
human donors with a wide age range (29 weeks to 88 
years). They found an inverse relationship between 
relative telomere length (rTL) and donor age, with the 
longest rTL detected in the youngest [35]. TL was 
significantly higher in blood compared to the majority of 
tissues but not different compared to adipose and renal 
tissue. The largest interindividual variability was 
observed in leucocytes and kidney [35]. Nonetheless, 
these results were confounded by the small number of 
donors and their variable health status. Up until now, 
little is known about the effect of injury and physical 
activity on telomere dynamics in human skeletal muscle. 
A recent study assessed whether aerobic capacity was 
associated with TL in skeletal muscles and leucocytes 
and whether TL is associated in these two tissues, across 
a wide age range (18–87 years). The findings support a 
correlation between LTL and mean skeletal muscles 
telomere length indicating that individuals with short (or 
long) telomeres in one tissue also display short (or long) 
telomeres in another tissue. However, skeletal muscle 
TL was not associated with age, and aerobic capacity 
was not associated with longer telomeres in either 
leukocytes or skeletal muscles [139]. Therefore, more 
studies are needed to consolidate our knowledge about 
tissue specific differences in telomere dynamics. 
 
To avoid invasive sample collection and regional 
variability of TL in solid organ tissues, blood leucocytes 
have been proposed as an alternative matrix for telomere 
analysis. Blood can easily be collected multiple times and 
LTL, at least theoretically, mirrors telomere dynamics in 
hematopoietic stem cells (hSC) and is an index of hSC 
reserve [165, 166]. However, blood leucocytes represent 
a heterogeneous cell population including monocytes, 
granulocytes and lymphocytes. The composition of this 
population is highly variable depending on stressors i.e. 
exercise, nutrition, smoking, psychological stress and 
others. These stressors can trigger a redistribution of 
leucocytes from immune reservoirs to the circulation and 
peripheral tissues [167]. As a result, the percentage of 
neutrophil granulocytes can range from 40 to 70% of the 
entire leucocyte count. Compared to many other cell 
types, neutrophils have a very short lifespan of 1-3 days. 
Therefore, it is not surprising that LTL exhibits by far the 
highest intra- and inter-individual variability amongst all 
sample types [35]. Conditions, such as CHIP, which arise 
from leucocyte precursor cells, may also influence the 
distribution of LTL and thus hamper the interpretation of 
LTL results. None withstanding the potential association 
between LTL and CHIP, which is primarily based on 
observational data, variable telomere attrition rates 
between individuals and amongst different solid tissues 
remain a major issue when interpreting the results of TL 
measurements. Therefore, more experimental data are 
needed to consolidate our knowledge about the 
relationship between TL in leucocytes and different solid 
tissues in the context of CHIP and other TL modifying 
conditions [168]. In summary, our present knowledge is 
insufficient to judge the validity of LTL as marker of 
biological age and as prognostic tool for poor outcomes 
and shorter DALYs in clinical settings. Furthermore,  
it is not clear how telomere dynamics of peripheral  
blood leucocytes reflect pathophysiological changes in 
individual organs. 
 
Besides the aforementioned pre-analytical issues, there 
are also analytical aspects that hamper a wider use of TL 
analysis. Existing methods are quantitative PCR (qPCR), 
Terminal Restriction Fragment (TRF) analysis by 
Southern blot, fluorescence in situ hybridization coupled 
with flow cytometry (flow-FISH), Single Telomere 
Length assay (STELA), Universal STELA, and Telomere 
Shortest Length Assay (TeSLA). Although all these 
methods analyse TL, the information they provide is 
substantially different and the results are not directly 
comparable [169]. Briefly, the qPCR assay is most 
frequently used in epidemiologic studies because it is 
easy to perform, requires small amounts of DNA and 
allows high throughput. The method provides a relative 
TL (T) compared to a single copy gene (S) and results are 
expressed as a T/S ratio. Information about the 
distribution of short and long telomeres, as well as 
differences between individual chromosomes and cells 
cannot be obtained. TRF is considered the “gold 
standard” for TL analysis that measures the intensity of 
telomere smears to determine an average TL. However, 
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applicability of this method is limited by the requirement 
of large amounts of DNA (approx. 3 µg) and a relatively 
laborious and time-consuming assay procedure, 
additionally with this technique very short telomeres 
(approx. 2 kb or less) are difficult to detect. Although 
reproducibility within the same laboratory can be rather 
good, results cannot easily be compared between 
laboratories. However, commercial TRF kits are now 
available and may help to improve inter-laboratory 
comparability. TL of peripheral blood leucocytes can also 
be measured by fluorescence in-situ hybridization (FISH) 
based methods. FISH based methods produce very 
reliable results, but are laborious and require expensive 
instrumentation [169]. Q-FISH expresses TL as relative 
fluorescence units. With the help of TRF measured 
standards absolute TLs can be derived. With this 
technique it has been shown that the shortest telomeres 
determine cell viability and chromosome stability [170–
172]. Reliable measurement of the shortest telomeres 
might open new possibilities for the assessment of 
biological age, the determination of individual risk for 
age-related degenerative disease and patient 
management. Finally, TeSLA assay, requires only small 
amounts (<1µg) of DNA and allows the unbiased 
measurement of TL distribution [173]. A wider use of 
TeSLA is hampered by its low throughput. Furthermore, 
very long telomeres, such as in inbred strains of mice, are 
not captured by this method. For a more comprehensive 
overview on the various techniques we refer to a recent 
review from Lai et al. [169]. Yet, for the measurement of 
TA the commonly used assay remains the Telomere-
Repeat Amplification Protocol (TRAP), a two-step 
procedure composed of telomerase mediated primer 
extension and PCR-based detection of extended products. 
This method has been further adapted to combine TRAP 
and droplet digital PCR (ddTRAP), thus increasing the 
sensitivity, repeatability and throughput of the assay. The 
specifics of the latter are reviewed by Ludlow at et al. 
[174, 175]. More laborious and not clinically used 
methods to detect TA include PCR-free assays such as 
electrochemical assays, optical assays, and signal-
transduction assays. However, all of them must be 
optimized to improve throughput and sensitivity and need 
special instrumentation to be performed [176]. 
 
In summary, telomere length and TA are almost 
exclusively measured in research laboratories. Sample 
matrix and analytical procedure should be carefully 
chosen for the intended use, and analyses should be 




Telomere research has gained much attention in the 
previous decade for its potential use and promise as a 
future therapeutic target, disease management and 
measurement of genomic aging. Interventions, such as 
physical activity that target the deleterious processes of 
aging have concomitantly created interest in the area of 
lifestyle and aging related research. Largely, the available 
physical activity data do not exclude that an association 
between regular exercise and TL exists. However, to 
date, the observed results from human studies are skewed 
largely by associations and observational or cross-
sectional data. In light of the limited data, available 
evidence suggests altogether, that regular, and consistent 
physical activity over an extended period of time may 
assist with preservation of telomeres and cellular aging. 
Nevertheless, conflicting and a lack of consistent findings 
from the existing evidence, and particularly from the few 
available mechanistic studies means there is much more 
to explore and understand, prior to measurements such as 
TL will be adopted clinically. 
 
Considering the above, future research should be 
focused on 1) developing more experimental data to 
further elucidate and confirm the relationship and 
mechanistic pathways between physical activity, aging 
and telomere biology, 2) investigating the effects of the 
use of different exercise modalities and intensities on 
telomeres and 3) further determining if these effects are 




Authors contributing to the presented manuscript writing 
and editing: MDS: manuscript conception, writing and 
editing; CS, MK, IL, GD: manuscript writing, editing and 
final approval; HJG, MH: manuscript conception, 
writing, editing and final approval. 
 
CONFLICTS OF INTEREST 
 









1. Roser M, Ortiz-Ospina E, Ritchie H. Life Expectancy. 
2019. https://ourworldindata.org/life-expectancy 
2. Oeppen J, Vaupel JW. Demography. Broken limits to 
life expectancy. Science. 2002; 296:1029–31. 
 https://doi.org/10.1126/science.1069675 
 PMID:12004104 
3. Christensen K, Doblhammer G, Rau R, Vaupel JW. 
Ageing populations: the challenges ahead. Lancet. 
2009; 374:1196–208. 
 
www.aging-us.com 13813 AGING 
 https://doi.org/10.1016/S0140-6736(09)61460-4 
 PMID:19801098 




5. Beltrán-Sánchez H, Soneji S, Crimmins EM. Past, 
Present, and Future of Healthy Life Expectancy. Cold 
Spring Harb Perspect Med. 2015; 5:a025957. 
 https://doi.org/10.1101/cshperspect.a025957 
 PMID:26525456 
6. Centers for Disease Control and Prevention (CDC). 
Control of infectious diseases. MMWR Morb Mortal 
Wkly Rep. 1999; 48:621–29. 
 PMID:10458535 
7. Tippett R. Mortality and Cause of Death, 1900 vs. 2010. 
Health & Environment; 2014.  
 https://www.ncdemography.org/2014/06/16/mortalit
y-and-cause-of-death-1900-v-2010/ 
8. World Health Organization. Deaths by cause, sex and 
mortality stratum in WHO regions, estimates for 2002, 
Annex Table 2.  
 https://www.who.int/whr/2002/en/whr2002_annex2.
pdf 
9. Ritchie H, Roser M. Causes of Death. 2019. 
https://ourworldindata.org/causes-of-death 
10. Institute for Health Metrics and Evaluation (IHME). 
Findings from the Global Burden of Disease Study 
2017. Seattle (WA): IHME; 2018. 
11. World Health Organization. Metrics: Disability-
Adjusted Life Year (DALY). Quantifying the Burden of 
Disease from mortality and morbidity. 
https://www.who.int/healthinfo/global_burden_disea
se/metrics_daly/en/ 
12. Ferioli M, Zauli G, Maiorano P, Milani D, Mirandola P, 
Neri LM. Role of physical exercise in the regulation of 
epigenetic mechanisms in inflammation, cancer, 
neurodegenerative diseases, and aging process. J Cell 
Physiol. 2019. [Epub ahead of print]. 
 https://doi.org/10.1002/jcp.28304 PMID:30767204 
13. Arem H, Moore SC, Patel A, Hartge P, Berrington de 
Gonzalez A, Visvanathan K, Campbell PT, Freedman M, 
Weiderpass E, Adami HO, Linet MS, Lee IM, Matthews 
CE. Leisure time physical activity and mortality: a 
detailed pooled analysis of the dose-response 
relationship. JAMA Intern Med. 2015; 175:959–67. 
 https://doi.org/10.1001/jamainternmed.2015.0533 
 PMID:25844730 
14. Ludlow AT, Ludlow LW, Roth SM. Do telomeres adapt 
to physiological stress? Exploring the effect of exercise 
on telomere length and telomere-related proteins. 
BioMed Res Int. 2013; 2013:601368. 
 https://doi.org/10.1155/2013/601368 
 PMID:24455708 
15. Harley CB, Futcher AB, Greider CW. Telomeres shorten 




16. Meyne J, Ratliff RL, Moyzis RK. Conservation of the 
human telomere sequence (TTAGGG)n among 
vertebrates. Proc Natl Acad Sci USA. 1989; 86:7049–53. 
 https://doi.org/10.1073/pnas.86.18.7049 
 PMID:2780561 
17. Blasco MA. Telomeres and human disease: ageing, 
cancer and beyond. Nat Rev Genet. 2005; 6:611–22. 
 https://doi.org/10.1038/nrg1656 PMID:16136653 
18. Blasco MA. Telomere length, stem cells and aging. Nat 
Chem Biol. 2007; 3:640–49. 
 https://doi.org/10.1038/nchembio.2007.38 
 PMID:17876321 




20. de Lange T. Shelterin: the protein complex that shapes 




21. Takai H, Smogorzewska A, de Lange T. DNA damage 




22. Artandi SE, Attardi LD. Pathways connecting telomeres 
and p53 in senescence, apoptosis, and cancer. 
Biochem Biophys Res Commun. 2005; 331:881–90. 
 https://doi.org/10.1016/j.bbrc.2005.03.211 
 PMID:15865944 
23. Palm W, de Lange T. How shelterin protects 




24. Lei M, Podell ER, Cech TR. Structure of human POT1 
bound to telomeric single-stranded DNA provides a 
model for chromosome end-protection. Nat Struct Mol 
Biol. 2004; 11:1223–29. 
 https://doi.org/10.1038/nsmb867 PMID:15558049 
25. Baumann P, Cech TR. Pot1, the putative telomere end-
binding protein in fission yeast and humans. Science. 
 




26. Loayza D, De Lange T. POT1 as a terminal transducer  




27. van Steensel B, de Lange T. Control of telomere length 




28. Teo H, Ghosh S, Luesch H, Ghosh A, Wong ET, Malik N, 
Orth A, de Jesus P, Perry AS, Oliver JD, Tran NL, Speiser 
LJ, Wong M, et al. Telomere-independent Rap1 is an 
IKK adaptor and regulates NF-kappaB-dependent gene 
expression. Nat Cell Biol. 2010; 12:758–67. 
 https://doi.org/10.1038/ncb2080 
 PMID:20622870 
29. Celli GB, de Lange T. DNA processing is not required for 
ATM-mediated telomere damage response after TRF2 
deletion. Nat Cell Biol. 2005; 7:712–18. 
 https://doi.org/10.1038/ncb1275 
 PMID:15968270 
30. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi 
A, Moss H, de Lange T. Mammalian telomeres end in a 
large duplex loop. Cell. 1999; 97:503–14. 
 https://doi.org/10.1016/S0092-8674(00)80760-6 
 PMID:10338214 
31. Diotti R, Loayza D. Shelterin complex and associated 
factors at human telomeres. Nucleus. 2011; 2:119–35. 
 https://doi.org/10.4161/nucl.2.2.15135 
 PMID:21738835 
32. Gomes NM, Ryder OA, Houck ML, Charter SJ, Walker 
W, Forsyth NR, Austad SN, Venditti C, Pagel M, Shay 
JW, Wright WE. Comparative biology of mammalian 
telomeres: hypotheses on ancestral states and the 
roles of telomeres in longevity determination. Aging 
Cell. 2011; 10:761–68. 
 https://doi.org/10.1111/j.1474-9726.2011.00718.x 
 PMID:21518243 
33. Sanders JL, Newman AB. Telomere length in 
epidemiology: a biomarker of aging, age-related 




34. Chen W, Kimura M, Kim S, Cao X, Srinivasan SR, 
Berenson GS, Kark JD, Aviv A. Longitudinal versus 
cross-sectional evaluations of leukocyte telomere 
length dynamics: age-dependent telomere shortening 




35. Dlouha D, Maluskova J, Kralova Lesna I, Lanska V, 
Hubacek JA. Comparison of the relative telomere length 
measured in leukocytes and eleven different human 
tissues. Physiol Res. 2014 (Suppl 3); 63:S343–50. 
 PMID:25428739 
36. von Zglinicki T, Saretzki G, Döcke W, Lotze C. Mild 
hyperoxia shortens telomeres and inhibits proliferation 




37. von Zglinicki T, Bürkle A, Kirkwood TB. Stress, DNA 
damage and ageing— an integrative approach. Exp 
Gerontol. 2001; 36:1049–62. 
 https://doi.org/10.1016/S0531-5565(01)00111-5 
 PMID:11404050 
38. von Zglinicki T, Martin-Ruiz CM. Telomeres as 
biomarkers for ageing and age-related diseases. Curr 
Mol Med. 2005; 5:197–203. 
 https://doi.org/10.2174/1566524053586545 
 PMID:15974873 
39. Sidorov I, Kimura M, Yashin A, Aviv A. Leukocyte 
telomere dynamics and human hematopoietic stem 




40. Greider CW, Blackburn EH. Identification of a specific 
telomere terminal transferase activity in Tetrahymena 
extracts. Cell. 1985; 43:405–13. 
 https://doi.org/10.1016/0092-8674(85)90170-9 
 PMID:3907856 
41. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, 
Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright 
WE. Extension of life-span by introduction of 




42. Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela 
ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, 
Flores JM, Viña J, Serrano M, Blasco MA. Telomerase 
reverse transcriptase delays aging in cancer-resistant 
mice. Cell. 2008; 135:609–22. 
 https://doi.org/10.1016/j.cell.2008.09.034 
 PMID:19013273 
43. Bernardes de Jesus B, Blasco MA. Aging by telomere 
loss can be reversed. Cell Stem Cell. 2011; 8:3–4. 
 
www.aging-us.com 13815 AGING 
 https://doi.org/10.1016/j.stem.2010.12.013 
 PMID:21211774 
44. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, 
Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J. The RNA 




45. Zheng Q, Huang J, Wang G. Mitochondria, Telomeres 




46. Zvereva MI, Shcherbakova DM, Dontsova OA. 
Telomerase: structure, functions, and activity 
regulation. Biochemistry (Mosc). 2010; 75:1563–83. 
 https://doi.org/10.1134/S0006297910130055 
 PMID:21417995 
47. Cong YS, Wright WE, Shay JW. Human telomerase  




48. Gu B, Bessler M, Mason PJ. Dyskerin, telomerase and 
the DNA damage response. Cell Cycle. 2009; 8:6–10. 
 https://doi.org/10.4161/cc.8.1.7265 
 PMID:19106610 
49. Teixeira MT, Arneric M, Sperisen P, Lingner J. Telomere 
length homeostasis is achieved via a switch between 




50. Schoeftner S, Blasco MA. Developmentally regulated 
transcription of mammalian telomeres by DNA-




51. Denham J, O’Brien BJ, Prestes PR, Brown NJ, Charchar 
FJ. Increased expression of telomere-regulating genes 
in endurance athletes with long leukocyte telomeres. J 
Appl Physiol (1985). 2016; 120:148–58. 
 https://doi.org/10.1152/japplphysiol.00587.2015 
 PMID:26586905 
52. Shay JW. Role of Telomeres and Telomerase in Aging 
and Cancer. Cancer Discov. 2016; 6:584–93. 
 https://doi.org/10.1158/2159-8290.CD-16-0062 
 PMID:27029895 
53. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, 
Greider C, DePinho RA. Longevity, stress response, and 




54. Kirwan M, Dokal I. Dyskeratosis congenita: a genetic 
disorder of many faces. Clin Genet. 2008; 73:103–12. 
 https://doi.org/10.1111/j.1399-0004.2007.00923.x 
 PMID:18005359 
55. Young NS. Telomere biology and telomere diseases: 
implications for practice and research. Hematology Am 
Soc Hematol Educ Program. 2010; 2010:30–35. 
 https://doi.org/10.1182/asheducation-2010.1.30 
 PMID:21239767 
56. Armanios M, Blackburn EH. The telomere syndromes. 
Nat Rev Genet. 2012; 13:693–704. 
 https://doi.org/10.1038/nrg3246 PMID:22965356 
57. Willeit P, Willeit J, Brandstätter A, Ehrlenbach S, Mayr 
A, Gasperi A, Weger S, Oberhollenzer F, Reindl M, 
Kronenberg F, Kiechl S. Cellular aging reflected by 
leukocyte telomere length predicts advanced 
atherosclerosis and cardiovascular disease risk. 
Arterioscler Thromb Vasc Biol. 2010; 30:1649–56. 
 https://doi.org/10.1161/ATVBAHA.110.205492 
 PMID:20508208 
58. Wilson WR, Herbert KE, Mistry Y, Stevens SE, Patel HR, 
Hastings RA, Thompson MM, Williams B. Blood 
leucocyte telomere DNA content predicts vascular 
telomere DNA content in humans with and without 
vascular disease. Eur Heart J. 2008; 29:2689–94. 
 https://doi.org/10.1093/eurheartj/ehn386 
 PMID:18762552 
59. Werner C, Fürster T, Widmann T, Pöss J, Roggia C, 
Hanhoun M, Scharhag J, Büchner N, Meyer T, 
Kindermann W, Haendeler J, Böhm M, Laufs U. Physical 
exercise prevents cellular senescence in circulating 




60. Samani NJ, Boultby R, Butler R, Thompson JR, Goodall 




61. Brouilette SW, Moore JS, McMahon AD, Thompson JR, 
Ford I, Shepherd J, Packard CJ, Samani NJ, and West of 
Scotland Coronary Prevention Study Group. Telomere 
length, risk of coronary heart disease, and statin 
treatment in the West of Scotland Primary Prevention 




www.aging-us.com 13816 AGING 
 PMID:17223473 
62. Wong LS, de Boer RA, Samani NJ, van Veldhuisen DJ, 
van der Harst P. Telomere biology in heart failure. Eur J 
Heart Fail. 2008; 10:1049–56. 
 https://doi.org/10.1016/j.ejheart.2008.08.007 
 PMID:18815070 
63. Goldman F, Bouarich R, Kulkarni S, Freeman S, Du HY, 
Harrington L, Mason PJ, Londoño-Vallejo A, Bessler M. 
The effect of TERC haploinsufficiency on the 




64. Armanios M, Alder JK, Parry EM, Karim B, Strong MA, 
Greider CW. Short telomeres are sufficient to cause the 
degenerative defects associated with aging. Am J Hum 
Genet. 2009; 85:823–32. 
 https://doi.org/10.1016/j.ajhg.2009.10.028 
 PMID:19944403 
65. Aviv A. Genetics of leukocyte telomere length  




66. Butt HZ, Atturu G, London NJ, Sayers RD, Bown MJ. 
Telomere length dynamics in vascular disease: a 
review. Eur J Vasc Endovasc Surg. 2010; 40:17–26. 
 https://doi.org/10.1016/j.ejvs.2010.04.012 
 PMID:20547081 
67. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, 
Morrow JD, Cawthon RM. Accelerated telomere 
shortening in response to life stress. Proc Natl Acad Sci 
USA. 2004; 101:17312–15. 
 https://doi.org/10.1073/pnas.0407162101 
 PMID:15574496 
68. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp 
C, Magbanua MJ, Marlin R, Yglecias L, Carroll PR, 
Blackburn EH. Increased telomerase activity and 
comprehensive lifestyle changes: a pilot study. Lancet 
Oncol. 2008; 9:1048–57. 
 https://doi.org/10.1016/S1470-2045(08)70234-1 
 PMID:18799354 
69. Paul L. Diet, nutrition and telomere length. J Nutr 
Biochem. 2011; 22:895–901. 
 https://doi.org/10.1016/j.jnutbio.2010.12.001 
 PMID:21429730 
70. Pusceddu I, Herrmann M, Kirsch SH, Werner C, 
Hübner U, Bodis M, Laufs U, Wagenpfeil S, Geisel J, 
Herrmann W. Prospective study of telomere length 
and LINE-1 methylation in peripheral blood cells: the 




71. Pusceddu I, Herrmann M, Kirsch SH, Werner C, Hübner 
U, Bodis M, Laufs U, Widmann T, Wagenpfeil S, Geisel 
J, Herrmann W. One-carbon metabolites and telomere 
length in a prospective and randomized study of  




72. Prasad KN, Wu M, Bondy SC. Telomere shortening 
during aging: attenuation by antioxidants and anti-




73. Tsoukalas D, Fragkiadaki P, Docea AO, Alegakis AK, 
Sarandi E, Vakonaki E, Salataj E, Kouvidi E, Nikitovic D, 
Kovatsi L, Spandidos DA, Tsatsakis A, Calina D. 
Association of nutraceutical supplements with longer 
telomere length. Int J Mol Med. 2019; 44:218–26. 
 https://doi.org/10.3892/ijmm.2019.4191 
 PMID:31115552 
74. An R, Yan H. Body weight status and telomere length in 




75. Ma Y, Bellini N, Scholten RH, Andersen MH, Vogel U, 
Saber AT, Loft S, Møller P, Roursgaard M. Effect of 
combustion-derived particles on genotoxicity and 
telomere length: A study on human cells and exposed 
populations. Toxicol Lett. 2020; 322:20–31. 
 https://doi.org/10.1016/j.toxlet.2020.01.002 
 PMID:31923465 
76. Febbraio MA. Exercise metabolism in 2016: health 
benefits of exercise - more than meets the eye! Nat 
Rev Endocrinol. 2017; 13:72–74. 
 https://doi.org/10.1038/nrendo.2016.218 
 PMID:28051119 
77. Boccardi M, Boccardi V. Psychological Wellbeing and 




78. Pusceddu I, Kleber M, Delgado G, Herrmann W, März 
W, Herrmann M. Telomere length and mortality in the 
Ludwigshafen Risk and Cardiovascular Health study. 
PLoS One. 2018; 13:e0198373. 
 https://doi.org/10.1371/journal.pone.0198373 
 PMID:29920523 
79. Goglin SE, Farzaneh-Far R, Epel ES, Lin J, Blackburn EH, 
 
www.aging-us.com 13817 AGING 
Whooley MA. Correction: Change in Leukocyte 
Telomere Length Predicts Mortality in Patients with 
Stable Coronary Heart Disease from the Heart and Soul 
Study. PLoS One. 2016; 11:e0168868. 
 https://doi.org/10.1371/journal.pone.0168868 
 PMID:27992608 
80. Mons U, Müezzinler A, Schöttker B, Dieffenbach AK, 
Butterbach K, Schick M, Peasey A, De Vivo I, 
Trichopoulou A, Boffetta P, Brenner H. Leukocyte 
Telomere Length and All-Cause, Cardiovascular 
Disease, and Cancer Mortality: Results From Individual-
Participant-Data Meta-Analysis of 2 Large Prospective 
Cohort Studies. Am J Epidemiol. 2017; 185:1317–26. 
 https://doi.org/10.1093/aje/kww210 
 PMID:28459963 
81. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, 
Brandstätter A, Kronenberg F, Kiechl S. Telomere 
length and risk of incident cancer and cancer mortality. 
JAMA. 2010; 304:69–75. 
 https://doi.org/10.1001/jama.2010.897 
 PMID:20606151 
82. Testa R, Olivieri F, Sirolla C, Spazzafumo L, Rippo MR, 
Marra M, Bonfigli AR, Ceriello A, Antonicelli R, 
Franceschi C, Castellucci C, Testa I, Procopio AD. 
Leukocyte telomere length is associated with 




83. Zhao J, Miao K, Wang H, Ding H, Wang DW. Association 
between telomere length and type 2 diabetes mellitus: 
a meta-analysis. PLoS One. 2013; 8:e79993. 
 https://doi.org/10.1371/journal.pone.0079993 
 PMID:24278229 
84. Aviv A, Levy D. Hemothelium, Clonal Hematopoiesis of 
Indeterminate Potential, and Atherosclerosis. 
Circulation. 2019; 139:7–9. 
 https://doi.org/10.1161/CIRCULATIONAHA.118.038434 
 PMID:30592656 
85. Xie M, Lu C, Wang J, McLellan MD, Johnson KJ, Wendl 
MC, McMichael JF, Schmidt HK, Yellapantula V, Miller 
CA, Ozenberger BA, Welch JS, Link DC, et al. Age-
related mutations associated with clonal 
hematopoietic expansion and malignancies. Nat Med. 
2014; 20:1472–78. 
 https://doi.org/10.1038/nm.3733 PMID:25326804 
86. Genovese G, Kähler AK, Handsaker RE, Lindberg J, Rose 
SA, Bakhoum SF, Chambert K, Mick E, Neale BM, 
Fromer M, Purcell SM, Svantesson O, Landén M, et al. 
Clonal hematopoiesis and blood-cancer risk inferred 




87. Jaiswal S, Fontanillas P, Flannick J, Manning A, 
Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, 
Chavez A, Higgins JM, Moltchanov V, Kuo FC, et al. Age-
related clonal hematopoiesis associated with adverse 
outcomes. N Engl J Med. 2014; 371:2488–98. 
 https://doi.org/10.1056/NEJMoa1408617 
 PMID:25426837 
88. Jaiswal S, Libby P. Clonal haematopoiesis: connecting 
ageing and inflammation in cardiovascular disease. Nat 
Rev Cardiol. 2020; 17:137–44. 
 https://doi.org/10.1038/s41569-019-0247-5 
 PMID:31406340 
89. Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson 
OT, Jonsdottir I, Thorgeirsson TE, Sigurdsson A, 
Gudjonsson SA, Gudmundsson J, Jonasson JG, 
Tryggvadottir L, Jonsson T, et al. Clonal hematopoiesis, 
with and without candidate driver mutations, is 
common in the elderly. Blood. 2017; 130:742–52. 
 https://doi.org/10.1182/blood-2017-02-769869 
 PMID:28483762 
90. Jaskelioff M, Muller FL, Paik JH, Thomas E, Jiang S, 
Adams AC, Sahin E, Kost-Alimova M, Protopopov A, 
Cadiñanos J, Horner JW, Maratos-Flier E, Depinho RA. 
Telomerase reactivation reverses tissue degeneration 




91. Shay JW, Bacchetti S. A survey of telomerase activity in 
human cancer. Eur J Cancer. 1997; 33:787–91. 
 https://doi.org/10.1016/S0959-8049(97)00062-2 
 PMID:9282118 
92. Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of 
telomeres and telomerase in cancer, and advances in 




93. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, 
Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, 
Weinberg RA. Inhibition of telomerase limits the 




94. Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, 
Shay JW, Corey DR. Inhibition of human telomerase in 
immortal human cells leads to progressive telomere 




www.aging-us.com 13818 AGING 
 PMID:10588696 
95. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO. 
Telomere shortening and apoptosis in telomerase-




96. Cassar L, Li H, Pinto AR, Nicholls C, Bayne S, Liu JP. 
Bone morphogenetic protein-7 inhibits telomerase 
activity, telomere maintenance, and cervical tumor 
growth. Cancer Res. 2008; 68:9157–66. 
 https://doi.org/10.1158/0008-5472.CAN-08-1323 
 PMID:19010887 
97. Yaswen P, MacKenzie KL, Keith WN, Hentosh P, Rodier 
F, Zhu J, Firestone GL, Matheu A, Carnero A, Bilsland A, 
Sundin T, Honoki K, Fujii H, et al. Therapeutic targeting 




98. Werner C, Hanhoun M, Widmann T, Kazakov A, 
Semenov A, Pöss J, Bauersachs J, Thum T, 
Pfreundschuh M, Müller P, Haendeler J, Böhm M, 
Laufs U. Effects of physical exercise on  
myocardial telomere-regulating proteins, survival 




99. Werner CM, Hecksteden A, Morsch A, Zundler J, 
Wegmann M, Kratzsch J, Thiery J, Hohl M, Bittenbring 
JT, Neumann F, Böhm M, Meyer T, Laufs U. Differential 
effects of endurance, interval, and resistance training 
on telomerase activity and telomere length in a 




100. Ludlow AT, Lima LC, Wang J, Hanson ED, Guth LM, 
Spangenburg EE, Roth SM. Exercise alters mRNA 
expression of telomere-repeat binding factor 1 in 




101. US Department of Health and Human Services. 
Physical activity guidelines advisory committee report, 
2008. pp. A1–H14.  
https://health.gov/sites/default/files/2019-
10/CommitteeReport_7.pdf 
102. Kokkinos P, Myers J. Exercise and physical activity: 




103. Ekelund U, Tarp J, Steene-Johannessen J, Hansen BH, 
Jefferis B, Fagerland MW, Whincup P, Diaz KM, 
Hooker SP, Chernofsky A, Larson MG, Spartano N, 
Vasan RS, et al. Dose-response associations between 
accelerometry measured physical activity and 
sedentary time and all cause mortality: systematic 




104. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh CC. 
Physical activity, all-cause mortality, and longevity of 
college alumni. N Engl J Med. 1986; 314:605–13. 
 https://doi.org/10.1056/NEJM198603063141003 
 PMID:3945246 
105. Fraser GE, Shavlik DJ. Ten years of life: is it a matter of 
choice? Arch Intern Med. 2001; 161:1645–52. 
 https://doi.org/10.1001/archinte.161.13.1645 
 PMID:11434797 
106. Franco OH, de Laet C, Peeters A, Jonker J, 
Mackenbach J, Nusselder W. Effects of physical 
activity on life expectancy with cardiovascular disease. 
Arch Intern Med. 2005; 165:2355–60. 
 https://doi.org/10.1001/archinte.165.20.2355 
 PMID:16287764 
107. Byberg L, Melhus H, Gedeborg R, Sundström J, 
Ahlbom A, Zethelius B, Berglund LG, Wolk A, 
Michaëlsson K. Total mortality after changes in leisure 
time physical activity in 50 year old men: 35 year 
follow-up of population based cohort. BMJ. 2009; 
338:b688. 
 https://doi.org/10.1136/bmj.b688 PMID:19264819 
108. Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, 
Chan HT, Tsao CK, Tsai SP, Wu X. Minimum amount of 
physical activity for reduced mortality and extended 




109. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz 
AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, 
Emplaincourt PO, Jacobs DR Jr, Leon AS. Compendium 
of physical activities: an update of activity codes and 




110. O’Donovan G, Lee IM, Hamer M, Stamatakis E. 
Association of “weekend warrior” and other leisure 
 
www.aging-us.com 13819 AGING 
time physical activity patterns with risks for all-cause, 
cardiovascular disease, and cancer mortality. JAMA 
Intern Med. 2017; 177:335–42. 
 https://doi.org/10.1001/jamainternmed.2016.8014 
 PMID:28097313 
111. Wenger HA, Bell GJ. The interactions of intensity, 
frequency and duration of exercise training in 




112. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, 
Wharton MB, McCartney JS, Bales CW, Henes S, 
Samsa GP, Otvos JD, Kulkarni KR, Slentz CA. Effects of 
the amount and intensity of exercise on plasma 
lipoproteins. N Engl J Med. 2002; 347:1483–92. 
 https://doi.org/10.1056/NEJMoa020194 
 PMID:12421890 
113. O’Donovan G, Owen A, Kearney EM, Jones DW, Nevill 
AM, Woolf-May K, Bird SR. Cardiovascular disease risk 
factors in habitual exercisers, lean sedentary men and 




114. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, 
Minson CT, Nigg CR, Salem GJ, Skinner JS, and 
American College of Sports Medicine. American 
College of Sports Medicine position stand. Exercise 
and physical activity for older adults. Med Sci Sports 
Exerc. 2009; 41:1510–30. 
 https://doi.org/10.1249/MSS.0b013e3181a0c95c 
 PMID:19516148 
115. de Vries NM, van Ravensberg CD, Hobbelen JS, Olde 
Rikkert MG, Staal JB, Nijhuis-van der Sanden MW. 
Effects of physical exercise therapy on mobility, 
physical functioning, physical activity and quality of 
life in community-dwelling older adults with impaired 
mobility, physical disability and/or multi-morbidity: a 
meta-analysis. Ageing Res Rev. 2012; 11:136–49. 
 https://doi.org/10.1016/j.arr.2011.11.002 
 PMID:22101330 
116. Faber MJ, Bosscher RJ, Chin A Paw MJ, van Wieringen 
PC. Effects of exercise programs on falls and mobility 
in frail and pre-frail older adults: A multicenter 




117. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, 
Chaddock L, Kim JS, Heo S, Alves H, White SM, 
Wojcicki TR, Mailey E, Vieira VJ, et al. Exercise training 
increases size of hippocampus and improves memory. 
Proc Natl Acad Sci USA. 2011; 108:3017–22. 
 https://doi.org/10.1073/pnas.1015950108 
 PMID:21282661 
118. Nagahara AH, Merrill DA, Coppola G, Tsukada S, 
Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, 
Conner JM, Rockenstein E, Chao MV, Koo EH, et al. 
Neuroprotective effects of brain-derived neurotrophic 
factor in rodent and primate models of Alzheimer’s 
disease. Nat Med. 2009; 15:331–37. 
 https://doi.org/10.1038/nm.1912 
 PMID:19198615 
119. Knaepen K, Goekint M, Heyman EM, Meeusen R. 
Neuroplasticity - exercise-induced response of 
peripheral brain-derived neurotrophic factor: a 
systematic review of experimental studies in human 
subjects. Sports Med. 2010; 40:765–801. 
 https://doi.org/10.2165/11534530-000000000-00000 
 PMID:20726622 
120. Meeusen R. Exercise, nutrition and the brain. Sports 
Med. 2014 (Suppl 1); 44:S47–56. 
 https://doi.org/10.1007/s40279-014-0150-5 
 PMID:24791916 
121. Lidzbarsky G, Gutman D, Shekhidem HA, Sharvit L, 
Atzmon G. Genomic Instabilities, Cellular Senescence, 
and Aging: In Vitro, In Vivo and Aging-Like Human 
Syndromes. Front Med (Lausanne). 2018; 5:104. 
 https://doi.org/10.3389/fmed.2018.00104 
 PMID:29719834 
122. Arsenis NC, You T, Ogawa EF, Tinsley GM, Zuo L. 
Physical activity and telomere length: impact of aging 




123. Ludlow AT, Witkowski S, Marshall MR, Wang J, Lima 
LC, Guth LM, Spangenburg EE, Roth SM. Chronic 
exercise modifies age-related telomere dynamics in a 




124. Ludlow AT, Gratidão L, Ludlow LW, Spangenburg EE, 
Roth SM. Acute exercise activates p38 MAPK and 
increases the expression of telomere-protective genes 
in cardiac muscle. Exp Physiol. 2017; 102:397–410. 
 https://doi.org/10.1113/EP086189 PMID:28166612 
125. Cherkas LF, Hunkin JL, Kato BS, Richards JB, Gardner 
JP, Surdulescu GL, Kimura M, Lu X, Spector TD, Aviv A. 
The association between physical activity in leisure 




www.aging-us.com 13820 AGING 
 PMID:18227361 
126. Du M, Prescott J, Kraft P, Han J, Giovannucci E, 
Hankinson SE, De Vivo I. Physical activity, sedentary 
behavior, and leukocyte telomere length in women. 
Am J Epidemiol. 2012; 175:414–22. 
 https://doi.org/10.1093/aje/kwr330 PMID:22302075 
127. Tucker LA. Physical activity and telomere length in 
U.S. men and women: an NHANES investigation. Prev 
Med. 2017; 100:145–51. 
 https://doi.org/10.1016/j.ypmed.2017.04.027 
 PMID:28450121 
128. LaRocca TJ, Seals DR, Pierce GL. Leukocyte telomere 
length is preserved with aging in endurance exercise-
trained adults and related to maximal aerobic 
capacity. Mech Ageing Dev. 2010; 131:165–67. 
 https://doi.org/10.1016/j.mad.2009.12.009 
 PMID:20064545 
129. Kim JH, Ko JH, Lee DC, Lim I, Bang H. Habitual physical 
exercise has beneficial effects on telomere length in 




130. Silva LC, de Araújo AL, Fernandes JR, Matias MS, Silva 
PR, Duarte AJ, Garcez Leme LE, Benard G. Moderate 
and intense exercise lifestyles attenuate the effects of 
aging on telomere length and the survival and 




131. Østhus IB, Sgura A, Berardinelli F, Alsnes IV, Brønstad 
E, Rehn T, Støbakk PK, Hatle H, Wisløff U, Nauman J. 
Telomere length and long-term endurance exercise: 
does exercise training affect biological age? A pilot 
study. PLoS One. 2012; 7:e52769. 
 https://doi.org/10.1371/journal.pone.0052769 
 PMID:23300766 
132. Chilton WL, Marques FZ, West J, Kannourakis G, 
Berzins SP, O’Brien BJ, Charchar FJ. Acute exercise 
leads to regulation of telomere-associated genes and 




133. Melk A, Tegtbur U, Hilfiker-Kleiner D, Eberhard J, 
Saretzki G, Eulert C, Kerling A, Nelius AK, Hömme M, 
Strunk D, Berliner D, Röntgen P, Kück M, et al. 
Improvement of biological age by physical activity. Int 
J Cardiol. 2014; 176:1187–89. 
 https://doi.org/10.1016/j.ijcard.2014.07.236 
 PMID:25223816 
134. Rae DE, Vignaud A, Butler-Browne GS, Thornell LE, 
Sinclair-Smith C, Derman EW, Lambert MI, Collins M. 
Skeletal muscle telomere length in healthy, 




135. Song Z, von Figura G, Liu Y, Kraus JM, Torrice C, Dillon 
P, Rudolph-Watabe M, Ju Z, Kestler HA, Sanoff H, 
Lenhard Rudolph K. Lifestyle impacts on the aging-
associated expression of biomarkers of DNA damage 




136. Mathur S, Ardestani A, Parker B, Cappizzi J, Polk D, 
Thompson PD. Telomere length and cardiorespiratory 




137. Soares-Miranda L, Imamura F, Siscovick D, Jenny NS, 
Fitzpatrick AL, Mozaffarian D. Physical activity, 
physical fitness and leukocyte telomere length: the 




138. von Känel R, Bruwer EJ, Hamer M, de Ridder JH, 
Malan L. Association between objectively measured 
physical activity, chronic stress and leukocyte 




139. Hiam D, Smith C, Voisin S, Denham J, Yan X, Landen S, 
Jacques M, Alvarez-Romero J, Garnham A, Woessner 
MN, Herrmann M, Duque G, Levinger I, Eynon N. 
Aerobic capacity and telomere length in human 
skeletal muscle and leukocytes across the lifespan. 
Aging (Albany NY). 2020; 12:359–69. 
 https://doi.org/10.18632/aging.102627 
 PMID:31901896 
140. Saßenroth D, Meyer A, Salewsky B, Kroh M, Norman 
K, Steinhagen-Thiessen E, Demuth I. Sports and 
exercise at different ages and leukocyte telomere 
length in later life–Data from the Berlin Aging Study II 
(BASE-II). PLoS One. 2015; 10:e0142131. 
 https://doi.org/10.1371/journal.pone.0142131 
 PMID:26630493 
141. Laine MK, Eriksson JG, Kujala UM, Raj R, Kaprio J, 
Bäckmand HM, Peltonen M, Sarna S. Effect of 
intensive exercise in early adult life on telomere 
 
www.aging-us.com 13821 AGING 
length in later life in men. J Sports Sci Med. 2015; 
14:239–45. 
 PMID:25983570 
142. Ludlow AT, Zimmerman JB, Witkowski S, Hearn JW, 
Hatfield BD, Roth SM. Relationship between physical 
activity level, telomere length, and telomerase 
activity. Med Sci Sports Exerc. 2008; 40:1764–71. 
 https://doi.org/10.1249/MSS.0b013e31817c92aa 
 PMID:18799986 
143. Savela S, Saijonmaa O, Strandberg TE, Koistinen P, 
Strandberg AY, Tilvis RS, Pitkälä KH, Miettinen TA, 
Fyhrquist F. Physical activity in midlife and telomere 




144. Denham J, Nelson CP, O’Brien BJ, Nankervis SA, 
Denniff M, Harvey JT, Marques FZ, Codd V, Zukowska-
Szczechowska E, Samani NJ, Tomaszewski M, Charchar 
FJ. Longer leukocyte telomeres are associated  
with ultra-endurance exercise independent of 
cardiovascular risk factors. PLoS One. 2013; 8:e69377. 
 https://doi.org/10.1371/journal.pone.0069377 
 PMID:23936000 
145. Woo J, Tang N, Leung J. No association between 
physical activity and telomere length in an elderly 
Chinese population 65 years and older. Arch Intern 
Med. 2008; 168:2163–64. 
 https://doi.org/10.1001/archinte.168.19.2163 
 PMID:18955647 
146. Krauss J, Farzaneh-Far R, Puterman E, Na B, Lin J, Epel 
E, Blackburn E, Whooley MA. Physical fitness and 
telomere length in patients with coronary heart 
disease: findings from the Heart and Soul Study. PLoS 
One. 2011; 6:e26983. 
 https://doi.org/10.1371/journal.pone.0026983 
 PMID:22096513 
147. Loprinzi PD, Sng E. Mode-specific physical activity and 
leukocyte telomere length among U.S. adults: 




148. Kadi F, Ponsot E, Piehl-Aulin K, Mackey A, Kjaer M, 
Oskarsson E, Holm L. The effects of regular strength 
training on telomere length in human skeletal muscle. 
Med Sci Sports Exerc. 2008; 40:82–87. 
 https://doi.org/10.1249/mss.0b013e3181596695 
 PMID:18091019 
149. Safdar A, Khrapko K, Flynn JM, Saleem A, De Lisio M, 
Johnston AP, Kratysberg Y, Samjoo IA, Kitaoka Y, 
Ogborn DI, Little JP, Raha S, Parise G, et al. Exercise-
induced mitochondrial p53 repairs mtDNA mutations 
in mutator mice. Skelet Muscle. 2016; 6:7. 
 https://doi.org/10.1186/s13395-016-0075-9 
 PMID:26834962 
150. Safdar A, Bourgeois JM, Ogborn DI, Little JP, Hettinga 
BP, Akhtar M, Thompson JE, Melov S, Mocellin NJ, 
Kujoth GC, Prolla TA, Tarnopolsky MA. Endurance 
exercise rescues progeroid aging and induces systemic 
mitochondrial rejuvenation in mtDNA mutator mice. 
Proc Natl Acad Sci USA. 2011; 108:4135–40. 
 https://doi.org/10.1073/pnas.1019581108 
 PMID:21368114 
151. Knutti D, Kressler D, Kralli A. Regulation of the 
transcriptional coactivator PGC-1 via MAPK-sensitive 




152. Puigserver P, Spiegelman BM. Peroxisome 
proliferator-activated receptor-gamma coactivator 1 
alpha (PGC-1 alpha): transcriptional coactivator and 
metabolic regulator. Endocr Rev. 2003; 24:78–90. 
 https://doi.org/10.1210/er.2002-0012 
 PMID:12588810 
153. Chan MC, Arany Z. The many roles of PGC-1α in 




154. Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-
1α, a nodal regulator of mitochondrial biogenesis. Am 
J Clin Nutr. 2011; 93:884S–90. 
 https://doi.org/10.3945/ajcn.110.001917 
 PMID:21289221 
155. Wright DC, Han DH, Garcia-Roves PM, Geiger PC, 
Jones TE, Holloszy JO. Exercise-induced mitochondrial 
biogenesis begins before the increase in muscle PGC-
1alpha expression. J Biol Chem. 2007; 282:194–99. 
 https://doi.org/10.1074/jbc.M606116200 
 PMID:17099248 
156. Diman A, Boros J, Poulain F, Rodriguez J, Purnelle M, 
Episkopou H, Bertrand L, Francaux M, Deldicque L, 
Decottignies A. Nuclear respiratory factor 1 and 
endurance exercise promote human telomere 
transcription. Sci Adv. 2016; 2:e1600031. 
 https://doi.org/10.1126/sciadv.1600031 
 PMID:27819056 
157. Sahin E, Colla S, Liesa M, Moslehi J, Müller FL, Guo M, 
Cooper M, Kotton D, Fabian AJ, Walkey C, Maser RS, 
Tonon G, Foerster F, et al. Telomere dysfunction 
induces metabolic and mitochondrial compromise. 
Nature. 2011; 470:359–65. 
 
www.aging-us.com 13822 AGING 
 https://doi.org/10.1038/nature09787 PMID:21307849 
158. de Carvalho Cunha VN, Dos Santos Rosa T, Sales MM, 
Sousa CV, da Silva Aguiar S, Deus LA, Simoes HG, de 
Andrade RV. Training Performed Above Lactate 
Threshold Decreases p53 and Shelterin Expression in 
Mice. Int J Sports Med. 2018; 39:704–11. 
 https://doi.org/10.1055/a-0631-3441 
 PMID:29945271 
159. Gobatto CA, de Mello MA, Sibuya CY, de Azevedo 
JR, dos Santos LA, Kokubun E. Maximal lactate 
steady state in rats submitted to swimming 
exercise. Comp Biochem Physiol A Mol Integr 
Physiol. 2001; 130:21–27. 
 https://doi.org/10.1016/S1095-6433(01)00362-2 
 PMID:11672680 
160. Zole E, Pliss L, Ranka R, Krumina A, Baumanis V. 
Dynamics of telomere length in different age 




161. Aviv A, Chen W, Gardner JP, Kimura M, Brimacombe 
M, Cao X, Srinivasan SR, Berenson GS. Leukocyte 
telomere dynamics: longitudinal findings among 
young adults in the Bogalusa Heart Study. Am J 
Epidemiol. 2009; 169:323–29. 
 https://doi.org/10.1093/aje/kwn338 
 PMID:19056834 
162. Benetos A, Kark JD, Susser E, Kimura M, Sinnreich R, 
Chen W, Steenstrup T, Christensen K, Herbig U, von 
Bornemann Hjelmborg J, Srinivasan SR, Berenson GS, 
Labat C, Aviv A. Tracking and fixed ranking of 
leukocyte telomere length across the adult life course. 
Aging Cell. 2013; 12:615–21. 
 https://doi.org/10.1111/acel.12086 
 PMID:23601089 
163. Verhulst S, Susser E, Factor-Litvak PR, Simons M, 
Benetos A, Steenstrup T, Kark JD, Aviv A. Response to: 
reliability and validity of telomere length 
measurements. Int J Epidemiol. 2016; 45:1298–301. 
 https://doi.org/10.1093/ije/dyw194 
 PMID:27880696 
164. Benetos A, Kimura M, Labat C, Buchoff GM, Huber S, 
Labat L, Lu X, Aviv A. A model of canine leukocyte 
telomere dynamics. Aging Cell. 2011; 10:991–95. 
 https://doi.org/10.1111/j.1474-9726.2011.00744.x 
 PMID:21917112 
165. Aviv A, Levy D. Telomeres, atherosclerosis, and the 




166. Hammadah M, Al Mheid I, Wilmot K, Ramadan R, 
Abdelhadi N, Alkhoder A, Obideen M, Pimple PM, 
Levantsevych O, Kelli HM, Shah A, Sun YV, Pearce B, 
et al. Telomere Shortening, Regenerative Capacity, 




167. Simpson RJ, Bigley AB, Agha N, Hanley PJ, Bollard 
CM. Mobilizing immune cells with exercise for  




168. Yeh JK, Lin MH, Wang CY. Telomeres as Therapeutic 




169. Lai TP, Wright WE, Shay JW. Comparison of telomere 
length measurement methods. Philos Trans R Soc 
Lond B Biol Sci. 2018; 373:20160451. 
 https://doi.org/10.1098/rstb.2016.0451 
 PMID:29335378 
170. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp 
PM, DePinho RA, Greider CW. Telomere shortening 
and tumor formation by mouse cells lacking 
telomerase RNA. Cell. 1997; 91:25–34. 
 https://doi.org/10.1016/S0092-8674(01)80006-4 
 PMID:9335332 
171. Hemann MT, Strong MA, Hao LY, Greider CW. The 
shortest telomere, not average telomere length, is 




172. Erdmann N, Liu Y, Harrington L. Distinct dosage 
requirements for the maintenance of long and short 
telomeres in mTert heterozygous mice. Proc Natl 
Acad Sci USA. 2004; 101:6080–85. 
 https://doi.org/10.1073/pnas.0401580101 
 PMID:15079066 
173. Lai TP, Wright WE, Shay JW. Generation of 
digoxigenin-incorporated probes to enhance DNA 
detection sensitivity. Biotechniques. 2016; 60:306–09. 
 https://doi.org/10.2144/000114427 PMID:27286808 
174. Ludlow AT, Robin JD, Sayed M, Litterst CM, Shelton 
DN, Shay JW, Wright WE. Quantitative telomerase 
enzyme activity determination using droplet digital 
PCR with single cell resolution. Nucleic Acids Res. 
2014; 42:e104. 
 https://doi.org/10.1093/nar/gku439 PMID:24861623 
 
www.aging-us.com 13823 AGING 
175. Ludlow AT, Shelton D, Wright WE, Shay JW. ddTRAP: A 
Method for Sensitive and Precise Quantification of 




176. Zhang X, Lou X, Xia F. Advances in the detection of 
telomerase activity using isothermal amplification. 
Theranostics. 2017; 7:1847–62. 
 https://doi.org/10.7150/thno.18930 PMID:28638472 
